Monogenic diabetes and neonatal diabetes — structured clinical encounter

Task

You are the paediatric registrar. A six-week-old, small-for-gestational-age infant has persistent insulin-requiring hyperglycaemia found during a febrile illness, with mild developmental delay and hypotonia. Work through the recognition, the acute stabilisation, the genetic pathway, and the conversation with the parents. [4]

Structure

1. Recognition (the six-month rule)

Diabetes diagnosed before six months is almost never autoimmune type 1, so the working diagnosis is monogenic neonatal diabetes until genetics proves otherwise; the work-up is molecular rather than antibody-based. The small-for-gestational-age history reflects foetal insulin deficiency, and the developmental delay with hypotonia raises a potassium-channel DEND phenotype. [1] [4]

2. Acute stabilisation

Secure the airway, breathing and circulation, correct dehydration and electrolyte disturbance, treat any intercurrent sepsis, and start an insulin infusion to bring the glucose into a safe range. Insulin is the bridge, not the destination: the priority is metabolic stability and protection of the developing brain while the gene is found. A continuous infusion at roughly 0.05 units per kilogram per hour, titrated to response, is a common specialist starting point. [1]

3. Genetic pathway

Send a targeted next-generation sequencing panel covering the neonatal diabetes genes — KCNJ11, ABCC8, INS, the 6q24 imprinting defect, and the rarer EIF2AK3, PDX1, FOXP3 and GATA6 — through a specialist monogenic service with genetic counselling, reserving whole-exome sequencing for a panel-negative or atypical case. [1] [5]

4. Confirming the gene and matching the drug

A confirmed activating KCNJ11 (or ABCC8) mutation allows a switch from insulin to oral glibenclamide, because the sulfonylurea closes the stuck-open channel directly, bypassing the faulty ATP-sensing step and restoring insulin release; the switch usually improves both glycaemia and the neurological features of DEND, and is best managed through a specialist centre experienced in glibenclamide conversion. [2] [3]

5. Family conversation

Explain to the parents that their baby's diabetes is caused by a single changed gene that can run in families, that an oral medicine is likely to replace the injections, that the same change may explain the developmental features and that genetic testing of the parents and future children is offered, and that the child will be cared for by a specialist team for life. Frame the conversation around the relief of a correct, treatable molecular diagnosis. [1]

6. Disposition and follow-up

Arrange lifelong shared care with a specialist monogenic diabetes service, a structured transition plan to adult care, cascade testing of first-degree relatives, reproductive genetic counselling for the family, and a correct patient identifier to prevent the wrong-diagnosis errors that recur across a lifetime of healthcare contacts. [1] [5]